Literature DB >> 20970405

CpG island hypermethylation of multiple tumor suppressor genes associated with loss of their protein expression during rat lung carcinogenesis induced by 3-methylcholanthrene and diethylnitrosamine.

Wen-bin Liu1, Lin Ao, Zi-yuan Zhou, Zhi-hong Cui, Yan-hong Zhou, Xiao-yan Yuan, Yun-long Xiang, Jia Cao, Jin-yi Liu.   

Abstract

The epigenetic mechanisms underlying the tumorigenesis caused by polycyclic aromatic hydrocarbons and nitrosamine compounds such as 3-methylcholanthrene (MCA) and diethylnitrosamine (DEN) are currently unknown. We reported previously that dynamic changes in DNA methylation occurred during MCA/DEN-induced rat lung carcinogenesis. Here, we used the same animal model to further study the evolution of methylation alterations in tumor suppressor genes (TSGs) DAPK1, FHIT, RASSF1A, and SOCS-3. We found that none of these genes were methylated in either normal or hyperplasia tissue. However, as the severity of the cancer progressed through squamous metaplasia and dysplasia to carcinoma in situ (CIS) and infiltrating carcinoma, so methylation became more prevalent. Particularly dramatic increases in the level of methylation, the average number of methylated genes, and the incidence of concurrent methylation in three genes were observed in CIS and infiltrating carcinoma. Similar but less profound changes were seen in squamous metaplasia and dysplasia. Furthermore, methylation status was closely correlated to loss of protein expression for these genes, with protein levels markedly declining along the continuum of carcinogenesis. These results suggest that progressive CpG island hypermethylation leading to inactivation of TSGs might be a vital molecular mechanism in the pathogenesis of MCA/DEN-induced multistep rat lung carcinogenesis.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20970405     DOI: 10.1016/j.bbrc.2010.10.061

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Systemic elevation of PTEN induces a tumor-suppressive metabolic state.

Authors:  Isabel Garcia-Cao; Min Sup Song; Robin M Hobbs; Gaelle Laurent; Carlotta Giorgi; Vincent C J de Boer; Dimitrios Anastasiou; Keisuke Ito; Atsuo T Sasaki; Lucia Rameh; Arkaitz Carracedo; Matthew G Vander Heiden; Lewis C Cantley; Paolo Pinton; Marcia C Haigis; Pier Paolo Pandolfi
Journal:  Cell       Date:  2012-03-06       Impact factor: 41.582

Review 2.  Mammalian models of chemically induced primary malignancies exploitable for imaging-based preclinical theragnostic research.

Authors:  Yewei Liu; Ting Yin; Yuanbo Feng; Marlein Miranda Cona; Gang Huang; Jianjun Liu; Shaoli Song; Yansheng Jiang; Qian Xia; Johannes V Swinnen; Guy Bormans; Uwe Himmelreich; Raymond Oyen; Yicheng Ni
Journal:  Quant Imaging Med Surg       Date:  2015-10

3.  Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.

Authors:  Guanghua Li; Jianbo Xu; Zhao Wang; Yujie Yuan; Yin Li; Shirong Cai; Yulong He
Journal:  J Cancer Res Clin Oncol       Date:  2014-09-28       Impact factor: 4.553

4.  LHX6 acts as a novel potential tumour suppressor with epigenetic inactivation in lung cancer.

Authors:  W-b Liu; X Jiang; F Han; Y-h Li; H-q Chen; Y Liu; J Cao; J-y Liu
Journal:  Cell Death Dis       Date:  2013-10-24       Impact factor: 8.469

5.  TGF-β mediated DNA methylation in prostate cancer.

Authors:  Chung Lee; Qiang Zhang; Xaolin Zi; Atreya Dash; Marcelo B Soares; Farahnaz Rahmatpanah; Zhenyu Jia; Michael McClelland; Dan Mercola
Journal:  Transl Androl Urol       Date:  2012-06

6.  Clinical significance of DAPK promoter hypermethylation in lung cancer: a meta-analysis.

Authors:  Ying Li; Min Zhu; Xiaoju Zhang; Dongjun Cheng; Xitao Ma
Journal:  Drug Des Devel Ther       Date:  2015-03-24       Impact factor: 4.162

7.  SOCS3 Methylation Predicts a Poor Prognosis in HBV Infection-Related Hepatocellular Carcinoma.

Authors:  Xin Zhang; Qingshan You; Xiaolei Zhang; Xiangmei Chen
Journal:  Int J Mol Sci       Date:  2015-09-18       Impact factor: 5.923

8.  Inhalable oridonin-loaded poly(lactic-co-glycolic)acid large porous microparticles for in situ treatment of primary non-small cell lung cancer.

Authors:  Lifei Zhu; Miao Li; Xiaoyan Liu; Lina Du; Yiguang Jin
Journal:  Acta Pharm Sin B       Date:  2016-12-22       Impact factor: 11.413

Review 9.  SOCS, inflammation, and cancer.

Authors:  Kyoko Inagaki-Ohara; Taisuke Kondo; Minako Ito; Akihiko Yoshimura
Journal:  JAKSTAT       Date:  2013-08-15

10.  TMEM196 acts as a novel functional tumour suppressor inactivated by DNA methylation and is a potential prognostic biomarker in lung cancer.

Authors:  Wen-bin Liu; Fei Han; Xiao Jiang; Hong-qiang Chen; Huan Zhao; Yong Liu; Yong-hong Li; Chuanshu Huang; Jia Cao; Jin-yi Liu
Journal:  Oncotarget       Date:  2015-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.